Dear Contractor

The Department of Health NI issued correspondence here dated 30 January 2026, extending the expiry date of SSP060 for Creon® 10,000 gastro-resistant capsules.

  • SSP060 will now expire on Friday 17 April 2026.

BACKGROUND

  • SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
  • SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
  • Pharmacists should refer to the latest versions of the existing SSPs which are now available on the Business Services Organisation dedicated page on its website HERE.
  • Operational guidance on the implementation of SSPs in Northern Ireland can be found on the BSO website HERE.

ACTION

Contractors should:

  • Review the letter here dated 30 January 2026, and ensure that their dispensary teams are aware of the extension of the expiry date of SSP060 to Friday 17 April 2026.
  • Note the specific details relating to these SSPs including guidance relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.

Contractors are reminded of information issued by BSO ‘Serious Shortage Protocols: Submission Information for Contractors’ which can be accessed here.

Contractors should contact their local SPPG office in the first instance should further information be required.  CPNI colleagues are also available for assistance.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

Dear Contractor
The Department of Health NI has issued correspondence here dated 30 January 2026 relating to the extension of SSP079, SSP080, SSP081 and SSP082 (Estradot® 25mcg patches, Estradot® 50mcg patches, Estradot® 75mcg patches and Estradot® 100mcg patches).  The letter advises that these SSPs have been extended to Friday 17 April 2026.

BACKGROUND

  • SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
  • SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
  • Pharmacists should refer to the latest versions of the existing SSPs which are now available on the Business Services Organisation dedicated page on its website HERE.
  • Operational guidance on the implementation of SSPs in Northern Ireland can be found on the BSO website HERE.

ACTION

Contractors should:

  • Review the letter here dated 30 January 2026, and ensure that their dispensary teams are aware of the extension of SSP079, SSP080, SSP081 and SSP082, and that they are also aware of the specific details relating to these SSPs; and
  • Note guidance relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.

Contractors are reminded of information issued by BSO ‘Serious Shortage Protocols: Submission Information for Contractors’ which can be accessed here.

Contractors should contact their local SPPG office in the first instance should further information be required.  CPNI colleagues are also available for assistance.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Expression of Interest – Yellow Card Champion

The Yellow Card Centre Northern Ireland is currently inviting volunteers to register their interest in the role of Yellow Card Champion.  This is a voluntary role open to staff in all areas of Health and Social Care, including community pharmacy.

Yellow Card champions will play a vital role in supporting pharmacovigilance and patient safety and will be supported by the Yellow Card centre Northern Ireland.

For further information email:  YCCNorthernIreland@belfasttrust.hscni.net

To register interest complete the online form: Yellow Card Champion Registration Form – Fill in form

‘Immunise, protect, thrive’ Living Well Campaign Goes Live

Siobhan McNulty, Living Well Campaign Champion launches the: ‘Immunise, protect, thrive’ campaign.

A new campaign – ‘immunise, protect, thrive’ – focussing on the importance of childhood immunisations has been launched in community pharmacies across Northern Ireland.

Running across February and March 2026, the campaign aims to raise awareness of the importance of vaccination and highlight that it is the most important thing you can do to protect your child from ill health.  The campaign social media schedule can be found here.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
The fourth update of concessionary prices were granted today for January 2026:
DrugPack
Size
Concessionary Price
Amiodarone 100mg tablets28£5.04
Amiodarone 200mg tablets28£9.59
Amisulpride 200mg tablets60£10.13
Amlodipine 2.5mg tablets28£3.58
Aripiprazole 2.5mg tablets28£29.69
Aspirin 75mg dispersible tablets28£3.05
(previously £2.19)
Aspirin 75mg dispersible tablets100£10.89
(previously £7.82)
Benzydamine 0.15% mouthwash sugar free300£3.17
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 0.4ml unit dose preservative free30£9.50
Ciprofloxacin 500mg tablets10£5.20
Clarithromycin 125mg/5ml oral suspension70£11.82
Clobazam 10mg tablets30£2.30
Clotrimazole 1% cream50£3.21
Clotrimazole 500mg pessaries1£5.04
Co-amilofruse 5mg/40mg tablets28£3.72
Co-careldopa 12.5mg/50mg tablets90£6.18
Co-codamol 30mg/500mg tablets30£1.40
Co-codamol 30mg/500mg tablets100£4.65
Dexamethasone 500microgram tablets28£1.75
Dipyridamole 200mg modified-release capsules60£40.13
Docusate 50mg/5ml oral solution sugar free300£15.59
Enalapril 2.5mg tablets28£4.16
Estradiol 10microgram pessaries24£10.57
Estriol 0.01% vaginal cream with applicator1£41.85
Famotidine 20mg tablets28£2.72
Haloperidol 1.5mg tablets28£4.21
Hydrocortisone 5mg tablets30£19.78
Hydroxocobalamin 1mg/1ml solution for injection ampoules5£9.77
Ibandronic acid 50mg tablets28£31.44
Irbesartan 150mg tablets28£4.10
(previously £2.01)
Itraconazole 100mg capsules15£4.86
Ivabradine 2.5mg tablets56£48.05
Lofepramine 70mg tablets56£22.93
Mebeverine 135mg tablets100£2.65
Mefenamic acid 500mg tablets28£29.75
Morphine sulfate 10mg/1ml solution for injection ampoules10£7.22
Nefopam 30mg tablets90£7.22
Nifedipine 5mg capsules90£43.99
Oxazepam 10mg tablets28£4.37
Oxazepam 15mg tablets28£6.54
Oxytetracycline 250mg tablets28£28.19
Piroxicam 0.5% gel112£2.60
Piroxicam 0.5% gel60£1.39
Pizotifen 1.5mg tablets28£1.29
Prochlorperazine 3mg buccal tablets50£12.95
Propranolol 80mg tablets56£3.88
Rabeprazole 10mg gastro-resistant tablets28£1.00
Risperidone 500microgram tablets20£2.52
Rosuvastatin 10mg tablets28£2.70
Rosuvastatin 20mg tablets28£1.40
Rosuvastatin 5mg tablets28£1.45
Sitagliptin 100mg/5ml oral solution sugar free150£19.85
Sotalol 40mg tablets28£0.96
Sotalol 80mg tablets28£4.95
Sulfasalazine 500mg tablets112£6.53
Timolol 0.25% eye drops5£2.85
Timolol 0.5% eye drops5£2.66
Tolterodine 1mg tablets56£11.85
Trihexyphenidyl 2mg tablets84£125.25
Trimethoprim 100mg tablets28£3.77
Trimethoprim 50mg/5ml oral suspension sugar free100£10.27

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The third update of concessionary prices were granted today for January 2026:
DrugPack SizeConcessionary Price
Aspirin 75mg tablets28£2.95
Chloramphenicol 0.5% eye drops10£2.75
Cimetidine 400mg tablets60£5.58
Co-codamol 30mg/500mg capsules100£5.68
Diclofenac sodium 50mg gastro-resistant tablets28£6.86
Glycerol 4g suppositories12£1.95
Indapamide 1.5mg modified-release tablets30£1.40
Memantine 10mg/ml oral solution sugar free50£9.15
Naproxen 250mg tablets28£0.79
Oxybutynin 5mg tablets56£3.85
Rabeprazole 20mg gastro-resistant tablets28£1.52
Ramipril 1.25mg capsules28£1.19
Ramipril 10mg capsules28£1.10
Ramipril 2.5mg capsules28£1.10
Ramipril 5mg capsules28£1.08
Ramipril 5mg tablets28£0.84
Thiamine 100mg tablets100£2.59

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
The Pharmaceutical Society of Northern Ireland (PSNI) issued correspondence to registrants on 26 January 2026 advising of the launch of the updated Code of Conduct, Ethics and Performance for Pharmacists in NI.

SUMMARY

  • The updated Code is available here.
  • The correspondence issued by PSNI Chief Executive Mr Canice Ward is available here.
  • Further information on how the updated Code has been developed and the key changes can be found on the PSNI website here.
  • PSNI has indicated that they will host webinars in late February to discuss how to use the Code to support best practice. Further information will issue in due course.

ACTION

  • Contractors are asked to read the correspondence regarding the updated Code, and share with all relevant members of the team.

Contractors can contact PSNI regarding any queries related to the Code, or alternatively they may speak to a member of the CPNI team.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive